3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
10
Neurofibromatosis 1
9
Breast Neoplasms
5
Neurofibroma, Plexiform
4
Lung Neoplasms
4
Triple Negative Breast Neoplasms
3
Neurofibrosarcoma
3
Thyroid Neoplasms
2
Neoplasms
2
Melanoma
2
Gallbladder Neoplasms
2
Uveal Melanoma
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Optic Nerve Glioma
1
Non-small Cell Lung Cancer Metastatic
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasm Metastasis
1
Meningioma
1
Liver Neoplasms
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Glioma
1
Interventions
Oxaliplatin
18
Surveys and Questionnaires
15
Fluorouracil
15
Capecitabine
13
Leucovorin
12
Blood Specimen Collection
11
Irinotecan
10
Standard of Care
7
Cisplatin
7
Endoscopic Mucosal Resection
6
atezolizumab
5
Specimen Handling
5
Radiotherapy
5
Educational Status
5
Drug Therapy
5
Docetaxel
5
S 1 (combination)
4
Radiosurgery
4
Nivolumab
4
Magnetic Resonance Spectroscopy
4
Interviews as Topic
4
Gemcitabine
4
Everolimus
4
Colonoscopy
4
Biopsy
4
Bevacizumab
4
tegafur-gimeracil-oteracil
3
pemigatinib
3
apatinib
3
Remote Patient Monitoring
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Neoplasms
×
AZD 6244
×
Clear all
NCT02450656
2018-08-27
M14AFS
The Netherlands Cancer Institute
Phase 1/2
Unknown
320 enrolled